PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma.
Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Baierl A, Kazakov D, Michal M, French LE, Hoetzenecker W, Schatton T, Asari R, Preusser M, Gnant M, Guenova E, Schoppmann SF.
Kollmann D, et al. Among authors: jedamzik j.
Oncoimmunology. 2018 Mar 13;7(6):e1435226. doi: 10.1080/2162402X.2018.1435226. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29872575
Free PMC article.